Research Article
Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy: OCT Angiography Findings and Risk Factors
Table 2
Optical coherence tomography parameters of study eyes.
| | Total (n = 108) | Group A (n = 31) | Group B (n = 77) | |
| CST, µm | 406.24 (129.46) | 406.84 (114.18) | 406.00 (135.82) | 0.709 | PED, n (%) | | | | 0.336 | Yes | 94 (87.04) | 29 (93.55) | 65 (84.41) | | No | 14 (12.96) | 2 (6.45) | 12 (15.58) | | PED height, µm | 58.99 (57.69) | 57.52 (28.61) | 59.58 (66.04) | 0.216 | PED width, µm | 671.53 (507.12) | 1107.13 (538.97) | 496.16 (372.62) | <0.001 | SCT, µm | 389.64 (101.71) | 376.90 (84.79) | 394.76 (107.86) | 0.622 | SRF height, µm | 206.78 (122.87) | 187.42 (98.41) | 214.57 (131.21) | 0.429 | SRF width, µm | 2712.70 (1344.70) | 2622.94 (908.59) | 2748.84 (1488.39) | 0.644 | IRF, n (%) | 1.00 | Yes | 1 (0.93) | 0 (0) | 1 (1.30) | | No | 107 (99.07) | 31 (100) | 76 (98.70) | |
|
|
Data are presented as mean (standard deviation) unless otherwise indicated. Student’s t-test; chi-squared test. CST, central subfield thickness; PED, pigment epithelial detachment; SCT, subfoveal choroidal thickness; SRF, subretinal fluid; IRF, intraretinal fluid. |